Froedtert & the Medical College of Wisconsin is recognized nationally for their Heated Intraperitoneal Chemotherapy (HIPEC) program. This facility is home to many physicians that are continuously researching and advancing HIPEC treatment for cancer patients.
The facility has hosted more than 3,100 research studies and clinical trials. In 2016, the institute had invested $225.3 million dollars in research and teaching.
439 of the physicians that represent Froedtert & the Medical College of Wisconsin are currently listed on the Best Doctors in America List for 2017-18.
Treating Patients With HIPEC
Sometimes a mesothelioma patient may experience cytoreductive surgery combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC). HIPEC is only performed after a patient has undergone cytoreductive surgery. This multimodal treatment method has been proven to help improve a patient’s life expectancy.
One of the peritoneal specialists at Froedtert is Dr. Harveshp Mogal. Watch what he has to say about what HIPEC can do for patients that experience it.
Froedtert’s HIPEC Buddy Program
Froedtert has an answer to help soothe this anxiety that a patient may have when it comes to the HIPEC procedure. The facility offers a program called the HIPEC Buddy.
Not only will a new patient in the HIPEC program get a better understanding of what they may experience, but they will not feel alone in the process. What a patient’s HIPEC Buddy cannot answer for them, Froedtert’s medical team will be able to address.
The Hub Model At Froedtert
The Clinical Cancer Center at Froedtert takes a unique approach to caring for their patients. They group all of their physicians and nurses by the types of cancer that they treat. Doing this makes it easier for a patient to access their medical caregivers because they are conveniently compiled into a team for them.
This patient-centered care model is very beneficial to patients that may be candidates for HIPEC. Each patient is appointed a patient coordinator who introduces them to the HIPEC program, gathers their medical records, and schedules consultations, and additional appointments.
Froedtert’s Peritoneal Specialist
Dr. Mogal specializes in surgical oncology. He is experienced in treating general gastrointestinal malignancies, melanomas, and sarcomas.
More importantly, he focuses on using Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) to treat the following cancers:
Dr. Mogal holds an interest in studying the outcomes of patients that have undergone therapy for tumors that have spread through their peritoneal cavity. For example, peritoneal mesothelioma patients experience this.
Peritoneal mesothelioma forms when ingested asbestos fibers become lodged in the peritoneum. Over time these fibers cause damage to cells and cause a tumor to form.
Dr. Mogal’s Academic Background
Dr. Mogal received his Doctor of Medicine in 2003. He earned it from the Patil University-University of Mumbai in Mumbai, India.
Following Mogal’s doctorate, he completed a residency in General Surgery at Grant Medical College and Sir JJ Group of Hospitals in Mumbai, India. He received further training in General Surgery at the St. Louis University Hospital in St. Louis, Missouri.
Mogal also did a fellowship in Complex Surgical Oncology at Wake Forest University School of Medicine in Winston-Salem, North Carolina. This facility was established in 1992 and it is considered one of the world’s largest centers for peritoneal surface malignancies.
You can reach her at 888-385-2024 extension 102 or firstname.lastname@example.org.